QR Pharma to Present at the 44th Winter Conference on Brain Research

Published: Jan 19, 2011

(BUSINESS WIRE)--QR Pharma, Inc., a developer of novel compounds to treat Alzheimer’s disease (AD), announced today that the company will be presenting a poster on the mechanism of action and clinical data of its lead compound Posiphen® and that Dr. Maria L. Maccecchini, CEO of QR, will be a symposium speaker at the 44th Winter Conference on Brain Research, January 22-27, 2011 in Keystone, Colorado.

Back to news